MGL-3196, a selective thyroid hormone receptor-beta agonist significantly decreases hepatic fat in NASH patients at 12 weeks, the primary endpoint in a 36 week serial liver biopsy study
Year: 2018
Type: article
Source: Journal of Hepatology
Authors: S. Harrison, S. Moussa, M. Bashir, N. Alkhouri, J. Frias, S. Baum, B. Tetri, M. Bansal, R. Taub
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2802388277